TY - JOUR
T1 - Hepatic uptake and deacylation of the LPS in bloodborne LPS-lipoprotein complexes
AU - Shao, Baomei
AU - Munford, Robert S.
AU - Kitchens, Richard
AU - Varley, Alan W.
N1 - Funding Information:
This work was supported by National Institutes of Health grants [AI-018188] and [AI-045896] from the National Institute of Allergy and Infectious Diseases; the Jan and Henri Bromberg Chair in Internal Medicine (UT-Southwestern); and, in part, by the Division of Intramural Research, NIAID, NIH. Acknowledgements Conflicts of interest
PY - 2012/12
Y1 - 2012/12
N2 - Much evidence indicates that bacterial LPS (endotoxin) is removed from the bloodstream mainly by the liver, yet the hepatic uptake mechanisms remain uncertain and controversial. In plasma, LPS can be either 'free' (as aggregates, bacterial membrane fragments or loosely bound to albumin, CD14, or other proteins) or 'bound' (complexed with lipoproteins). Whereas most free LPS is taken up by Kupffer cells (KCs), lipoprotein-bound LPS has seemed to be cleared principally by hepatocytes. Here, we compared the liver's ability to take up and deacylate free LPS aggregates and the LPS in preformed LPS-high density lipoprotein (HDL) complexes. In mice examined from 1 h to 7 d after a small amount of fluorescent (FITC-)LPS was injected into a lateral tail vein, we found FITC-LPS almost entirely within, or adjacent to, KCs. As expected, FITC-LPS complexed with HDL (FITC-LPS-HDL) disappeared more slowly from the circulation and a smaller fraction of the injected dose of FITC-LPS was found in the liver. Unexpectedly, the FITC-LPS injected as FITC-LPS-HDL complexes was also found within sinusoids, adjacent to, or within, KCs. In other experiments, we found that both free and HDL-bound radiolabeled LPS underwent enzymatic deacylation by acyloxyacyl hydrolase (AOAH), the LPS-inactivating enzyme that is principally produced within the liver by KCs. Our observations suggest that KCs and AOAH play important roles in clearing and catabolizing both free LPS and the LPS in circulating LPS-HDL complexes.
AB - Much evidence indicates that bacterial LPS (endotoxin) is removed from the bloodstream mainly by the liver, yet the hepatic uptake mechanisms remain uncertain and controversial. In plasma, LPS can be either 'free' (as aggregates, bacterial membrane fragments or loosely bound to albumin, CD14, or other proteins) or 'bound' (complexed with lipoproteins). Whereas most free LPS is taken up by Kupffer cells (KCs), lipoprotein-bound LPS has seemed to be cleared principally by hepatocytes. Here, we compared the liver's ability to take up and deacylate free LPS aggregates and the LPS in preformed LPS-high density lipoprotein (HDL) complexes. In mice examined from 1 h to 7 d after a small amount of fluorescent (FITC-)LPS was injected into a lateral tail vein, we found FITC-LPS almost entirely within, or adjacent to, KCs. As expected, FITC-LPS complexed with HDL (FITC-LPS-HDL) disappeared more slowly from the circulation and a smaller fraction of the injected dose of FITC-LPS was found in the liver. Unexpectedly, the FITC-LPS injected as FITC-LPS-HDL complexes was also found within sinusoids, adjacent to, or within, KCs. In other experiments, we found that both free and HDL-bound radiolabeled LPS underwent enzymatic deacylation by acyloxyacyl hydrolase (AOAH), the LPS-inactivating enzyme that is principally produced within the liver by KCs. Our observations suggest that KCs and AOAH play important roles in clearing and catabolizing both free LPS and the LPS in circulating LPS-HDL complexes.
KW - HDL
KW - Kupffer cell
KW - LPS
KW - acyloxyacyl hydrolase
KW - endotoxin
UR - http://www.scopus.com/inward/record.url?scp=84870003651&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84870003651&partnerID=8YFLogxK
U2 - 10.1177/1753425912442431
DO - 10.1177/1753425912442431
M3 - Article
C2 - 22441700
AN - SCOPUS:84870003651
SN - 1753-4259
VL - 18
SP - 825
EP - 833
JO - Innate Immunity
JF - Innate Immunity
IS - 6
ER -